Notable candidates in Phase II/III trials include arhalofenate (MBX102), AC201, the RDEA group (including lesinurad), tranilast, and ulodesine (BCX4208)
Supplementing with Glutathione 1500mg directly supports this critical detoxification pathway, particularly important for individuals with high toxic exposure, liver conditions, or metabolic stress
[ CrossRef ] [ Google scholar ] [ PubMed ] Yang Z, Balic A, Michon F, Juuri E, Thesleff I
BPC 157 has been shown to possess anti-inflammatory properties potentially helping manage discomfort
All orders are reviewed before dispatch